NutriBand (NTRB) Current Assets (2016 - 2026)
NutriBand (NTRB) posted Current Assets of $4.4 million for Q2 2026, down 12.28% sequentially from $5.0 million in Q1 2026, and up 27.6% YoY from $3.4 million in Q2 2025.
NutriBand (NTRB) Current Assets (2016 - 2026) Analysis & Trends
NutriBand has reported Current Assets for 11 years, with the latest figure at $4.4 million in Q2 2026.
- Quarterly Current Assets rose 27.6% year-over-year to $4.4 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $4.4 million (up 27.6% YoY) and the FY2026 annual result came in at $5.0 million, up 4.06% from the prior year.
- Current Assets retreated to $4.4 million in Q2 2026 per NTRB's latest filing, from $5.0 million in the prior quarter.
- Over five years, Current Assets peaked at $8.7 million in Q2 2024 and troughed at $1.0 million in Q1 2024.
- A 5-year average of $4.5 million and a median of $4.5 million in 2022 frame the typical range for Current Assets.
- The sharpest annual moves came in 2022 and 2024: Current Assets surged 1639.52% in 2022, then tumbled 62.07% in 2024.
- Over 5 years, Current Assets stood at $3.5 million in 2022, then tumbled by 42.98% to $2.0 million in 2023, then jumped by 209.62% to $6.2 million in 2024, then slipped by 6.08% to $5.8 million in 2025, then slipped by 24.74% to $4.4 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $4.4 million, $5.0 million, and $5.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.76 Bn |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 | 4.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 4.38 Mn |
| Jan 31, 2026 | 4.99 Mn |
| Oct 31, 2025 | 5.82 Mn |
| Jul 31, 2025 | 7.52 Mn |
| Apr 30, 2025 | 3.43 Mn |
| Jan 31, 2025 | 4.79 Mn |
| Oct 31, 2024 | 6.19 Mn |
| Jul 31, 2024 | 7.25 Mn |
| Apr 30, 2024 | 8.73 Mn |
| Jan 31, 2024 | 1.02 Mn |
| Oct 31, 2023 | 2.00 Mn |
| Jul 31, 2023 | 3.27 Mn |
| Apr 30, 2023 | 1.99 Mn |
| Jan 31, 2023 | 2.69 Mn |
| Oct 31, 2022 | 3.51 Mn |
| Jul 31, 2022 | 4.11 Mn |
| Apr 30, 2022 | 4.64 Mn |
| Jan 31, 2022 | 5.47 Mn |
| Oct 31, 2021 | 5.95 Mn |
| Jul 31, 2021 | 606,750.00 |